Latest News • The Mendocino Voice | Mendocino County, CAThe ...
therapeutics and clinical risk management :: Article Creator Anavo Therapeutics Strengthens Management Team Anavo Therapeutics Strengthens Management Team The company appoints industry veteran Shaun McNulty as Chief Scientific Officer and welcomes R&D expert Anna Quattropani as Senior Vice President of Chemistry & Non-Clinical Development Anavo Therapeutics, a global leader in unlocking the full therapeutic potential of phosphatase biology, announced the appointment of Shaun McNulty, DPhil, as Chief Scientific Officer (CSO) and the appointment of Anna Quattropani, PhD, as Senior Vice President of Chemistry and Non-Clinical Development. Dr. McNulty will oversee the implementation of Anavo's strategy from discovery into clinical development and, together with Dr. Quattropani and Anavo's management team, the continued design of Anavo's first- and best-in-class phosphatase-targeting allosteric modulators. "We are fortunate...